Media ReleasesCyclopharm

View All Cyclopharm News


Cyclopharm Receives $3.1M R&D Tax Incentive for FY2020


AusIndustry has approved Cyclopharm Limited’s (ASX: CYC) inclusion of certain expensed costs associated with its overseas research and domestic development activities as part of its application for a research and development tax incentive.

Cyclopharm confirms it has completed its Research and Development Tax incentive claim for the 2020 financial year and has been notified that it will receive a cash payment of $3.10 million (vs 2019: $3.01 million). 

For more information, download the attached PDF.

Download this document